Back to results

Thought Field Therapy and Cognitive Therapy for Agoraphobia

Primary Purpose

Agoraphobia

Status

Completed

Phase

Not Applicable

Locations

Norway

Study Type

Interventional

Intervention

Thought field therapy

Cognitive therapy

Wait list

About this trial

This is an interventional treatment trial for Agoraphobia focused on measuring Agoraphobia, Cognitive therapy, Thought field therapy, Psychotherapy research

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Patients ages 18 years or older,
Patients with agoraphobia,
Patients with a score on Mobility Inventory "Alone" of 2.5 or more,
Patients who give a written consent to participate.

Exclusion Criteria:

Psychosis (past or present),
Drug abuse or dependency,
Moderate or high score on suicidal behaviour on the M.I.N.I.,
Patients who have another illness (other than panic disorder or agoraphobia) and are in need of immediate treatment.

Sites / Locations

Sorlandet Hospital

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Other

Arm Label

Thought field therapy

Cognitive therapy

Wait list

Arm Description

24 randomly selected patients will be treated with 5 sessions of standard Thought field therapy.

Treatment with Cognitive therapy, 12 sessions with manualized therapy according to David Clark's model.

24 patients will be randomly selected to 3 months on a wait list, thereafter randomly selected to either Cognitive therapy or Thought field therapy.

Outcomes

Primary Outcome Measures

Change in agoraphobic situation scores in ADIS.

Secondary Outcome Measures

Interference score in ADIS

Mobility Inventory

Agoraphobic Cognitions Questionnaire

Body Sensations Questionnaire

BDI

BAI

WHOQOL-BREF

SF-36

Safety Seeking Behaviours Questionnaire.

Panic scale

Full Information

NCT ID

NCT00932919

First Posted

July 3, 2009

Last Updated

April 22, 2014

Sponsor

Sorlandet Hospital HF

1. Study Identification

Unique Protocol Identification Number

NCT00932919

Brief Title

Thought Field Therapy and Cognitive Therapy for Agoraphobia

Official Title

Thought Field Therapy and Cognitive Therapy for Agoraphobia - a Randomized Controlled Intervention Study Where the Efficacy of Thought Field Therapy is to be Compared to Cognitive Therapy

Study Type

Interventional

2. Study Status

Record Verification Date

April 2014

Overall Recruitment Status

Completed

Study Start Date

October 2006 (undefined)

Primary Completion Date

November 2010 (Actual)

Study Completion Date

November 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title

Sponsor

Name of the Sponsor

Sorlandet Hospital HF

4. Oversight

Data Monitoring Committee

5. Study Description

Brief Summary

The purpose for this study is to find out if Thought field therapy has the same effect as, or better effect than, Cognitive therapy for Agoraphobia.

Detailed Description

Thought field therapy is an alternative treatment method that has shown, by casuistic reports, to give good results when applied for anxiety disorders. In this study 72 patients will be randomized to three groups. 24 patients will receive cognitive therapy as a control method, 24 patients will receive thought field therapy. The remaining 24 patients will wait three months, and then be randomized to either of the two therapies. Before inclusion all patients will be diagnosed with M.I.N.I. and SCID II. They will fill out self evaluation forms for symptoms and quality of life, before and after treatment, and one year after treatment. All patients will undergo an interview with ADIS on panic and agoraphobic diagnosis and symptoms before starting treatment, and on panic and agoraphobic symptoms immediately after and one year after treatment. These interviews will be done by psychologists who are blinded for which type of treatment the patients have got.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study

Agoraphobia

Keywords

Agoraphobia, Cognitive therapy, Thought field therapy, Psychotherapy research

7. Study Design

Primary Purpose

Treatment

Study Phase

Not Applicable

Interventional Study Model

Single Group Assignment

Masking

Outcomes Assessor

Allocation

Randomized

Enrollment

72 (Actual)

8. Arms, Groups, and Interventions

Arm Title

Thought field therapy

Arm Type

Experimental

Arm Description

24 randomly selected patients will be treated with 5 sessions of standard Thought field therapy.

Arm Title

Cognitive therapy

Arm Type

Active Comparator

Arm Description

Treatment with Cognitive therapy, 12 sessions with manualized therapy according to David Clark's model.

Arm Title

Wait list

Arm Type

Other

Arm Description

24 patients will be randomly selected to 3 months on a wait list, thereafter randomly selected to either Cognitive therapy or Thought field therapy.

Intervention Type

Behavioral

Intervention Name(s)

Thought field therapy

Other Intervention Name(s)

TFT

Intervention Description

5 sessions with Thought field therapy

Intervention Type

Behavioral

Intervention Name(s)

Cognitive therapy

Other Intervention Name(s)

CBT

Intervention Description

12 sessions of Cognitive therapy

Intervention Type

Behavioral

Intervention Name(s)

Wait list

Other Intervention Name(s)

Intervention Description

3 months waiting, then randomized to either thought field therapy or cognitive therapy

Primary Outcome Measure Information:

Title

Change in agoraphobic situation scores in ADIS.

Time Frame

Immedeately and 12 months after treatment

Secondary Outcome Measure Information:

Title

Interference score in ADIS

Time Frame